Takeaway

Patients with primary stage III epithelial ovarian cancer who are ineligible for primary cytoreduction surgery benefit from administered chemotherapy that has been heated to 42 C following interval cytoreductive surgery. This ‘hyperthermic intraperitoneal chemotherapy’ (HIPEC) targets microscopic residual cancerous tissue on the peritoneal surface. Targeting the surface directly maximises ...